University of Scranton

Global Cancer Technology-Developing unique and novel nanoparticles for treating COVID-19 and "remote controlled cancer drug delivery"

De

══ CONVEYANCE ══ 
I was approached by a scientist from the UCSD/ John Moore’s Cancer Institute to see if I’d have an interest in some technology that utilized my radiation technology into a new drug delivery technology. I was introduced to this cancer intellectual property and several other available patents that we could license. I quickly saw the commercial opportunity that the patents represented. This is what launched Global Cancer Technology. Even today, we are still acquiring various technologies from different medical institutions.

Also in medical devices, we now have a fourth technology which is a new way to mark and track medical instruments using invisible nano-quantum dots and advanced optical recording. This tool holds great potential. In everyone’s business, there is something uniquely different. It’s one of the compelling reasons why that individual started the business. The technologies I’m involved in are unique and different from any competing technologies. I won’t go into any new technologies without that being foremost in my mind.

Our basic cancer technologies will be solving a multitude of problems for those individuals facing this dreaded disease. We are solely focusing on this achievement. Our other technologies will likewise all the multitude of biological conditions and that is what we hope to do.

══ SPECIALTIES ══ 
Medical Devices | Drug Delivery | Medical Instrument Marketing | High Intensity Focused Ultrasound | Clinical Research | Medicine | Healthcare Management | Product Launch | Product Development | Healthcare Information Technology | Cancer | Orthopedics | Surgery | Hospitals | Lifesciences | Medical | Imaging | Public Health | Product Development | Venture Capital | Start-ups | Business Development | Market Development | Entrepreneurship

Global Cancer Technology

CEO & Founder

It’s a privilege to serve on the Palomar Health Board of Directors and as their Treasurer.

══ ATTENTIVENESS ══ 
My main duties as treasurer are to oversee the financial administration and affairs of the organization, review procedures and financial reporting, advise the board on financial strategy, and advice on fundraising.

Because we sympathize with the necessity of leveraging the high costs associated with the provision of health care services, we have concentrated our efforts on creating a coordinated system of care that concentrates technology, expertise, and volume in specific locations where high competency can be maintained. We presently have a North County delivery system anchored by three hospitals, two of which provide an assortment of acute care services and one specialty hospital focused on Obstetrics, Rehabilitation, Behavioral Health, Pediatrics, and Neonatal Intensive Care.

Our Mission is to heal, comfort, and promote health in the communities we serve. Our vision is to be the health system of choice for patients, physicians, and employees, recognized nationally for the highest quality of clinical care and access to comprehensive services. Our values include the compassion of providing comfort and care, the integrity of doing the right thing for the right reason, the teamwork of working together for shared goals, the excellence of being the best, the service of serving others and our community, and the trust of delivering on promises.

══ SPECIALTIES ══ 
Medical Devices | Drug Delivery | Medical Instrument Marketing | High Intensity Focused Ultrasound | Clinical Research | Medicine | Healthcare Management | Product Launch | Product Development | Healthcare Information Technology | Cancer | Orthopedics | Surgery | Hospitals | Lifesciences | Medical | Imaging | Public Health | Product Development | Venture Capital | Start-ups | Business Development | Market Development | Entrepreneurship

Palomar Health

Palomar Health-Board of Director-Treasurer: 

NanoMed Tracking(2017)-­‐(Subsidiary of GCT)
And innovative, unique and disruptive technology to track hospital instruments using an applied nano – quantum dot polymer (nQD) and an optical scanner system. Even materials as small as sutures can be labeled and tracked. This gives hospitals a new dimension in inventory control. By the year 2020, the FDA has mandated that all hospitals in the US must have an inventory tracking system in place

NanoMed Tracking- (subsidiary of Global Cancer Technology)

NanoDrug Transport has licensed proprietary IP from scientists at the UCSD- John Moores Cancer Center for a new cancer drug transport technology. Currently, when patients are injected with a cancer treating drug, much of the drug's energy is spent by the time it is absorbed at the tumor site. Our technology can solve this problem as we are  keep the drug in-active by binding the cancer drug to a nano Crystal scintillator, which transports to the drug to the tumor site. Once at the tumor site, external radiation is delivered to the tumor site, breaking the bonds and allowing 100% of the drugs energy to be available.

John Clark